Cell-therapy quality control asks three questions: Is the batch potent, authentic, and consistent with the next batch?
Cell-therapy quality control asks three questions: Is the batch potent, authentic, and consistent with the next batch?
More from this video
See all →Some blue-zone longevity findings were undermined when investigators found reported centenarians…
@businessJapan tightened IPO standards after too many low-quality zombie companies reached the stock…
@businessTwo biological-age tests can disagree because blood markers, sleep patterns, and stress measure…
@businessIn biological AI, missing or mismatched data can matter more than sophisticated modeling.
@businessA practical AI-biology workflow generates purpose-built data first, then applies simple models to…
@businessAging therapies need infrastructure that measures aging before their effects can be clinically…
@businessGreat companies are bought, not sold. Strong demand creates multiple offers. Chasing buyers tends…
@businessLong-term platform value can justify sacrificing short-term revenue if better methods eventually…
@businessDon't lose this one
A free account saves cards like this to your Collection, and Korva resurfaces them so you actually remember.